Healthcare / Medical Care FacilitiesSaudi
$49.00
+0.50 (+1.03%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 17%
FCF escenarios
weak_data · normalized FCF $-12.1M · quality 39.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
51/100
C
Piotroski
4/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$515M
P/E
18.7x
↓EV/EBITDA
14.3x
↑ROE
12.4%
↑Gross Margin
32.8%
↓Debt/Equity
0.55
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+15.9%
FCF CAGR
—
FCF margin
-25.4%
FCF / Net income
-1.86x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $201.8M · net income $27.5M · FCF $-51.2M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $201.8M | $201.8M | $194.3M | $182.4M | $129.7M |
| Net Income | $27.5M | $27.5M | $21.8M | $52.4M | $26.9M |
| EBITDA | $43.3M | $43.3M | $36.9M | $65.0M | $36.0M |
| EPS | — | — | 2.07 | 4.99 | 2.56 |
| Gross Margin | 32.8% | 32.8% | 32.1% | 40.5% | 39.8% |
| Operating Margin | 15.3% | 15.3% | 12.6% | 23.6% | 21.8% |
| Net Margin | 13.6% | 13.6% | 11.2% | 28.7% | 20.8% |
| Balance Sheet | |||||
| Debt/Equity | 0.55 | 0.55 | 0.45 | 0.27 | 0.17 |
| Current Ratio | 6.26 | 6.26 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-51.2M | $-51.2M | $-3.2M | $-12.1M | $24.4M |
| Returns | |||||
| ROE | 12.4% | 12.4% | 10.9% | 29.1% | 20.7% |
| Valuation | |||||
| P/E | 18.70 | 18.70 | 38.16 | 11.80 | 11.35 |
| EV/EBITDA | 14.27 | 14.27 | 23.76 | 10.17 | 8.70 |
| P/B | 2.31 | 2.31 | 4.15 | 3.43 | 2.35 |
| Growth & Yield | |||||
| Revenue Growth | 3.9% | 3.9% | 6.5% | 40.6% | — |
| EPS Growth | — | — | -58.5% | 94.9% | — |
| Dividend Yield | 0.7% | 0.7% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-24.5%
Start / end P/E
n/dx → n/dx
EPS bridge
2.07 → n/d
Residual
-25.2%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.